美国国家转化科学促进中心（NCATS）是NIH的27个研究所和中心之一，成立于2011年12月。自成立以来，NCATS管理着广泛的资助组合，包括NIH最大的单一资助计划，临床和转化科学奖（CTSA）。
NCATS的工作人员努力应对罕见疾病研究的巨大挑战，以便新的治疗方法可以更快地到达人们手中。他们专注于疾病中的常见情况，并开发解决方案，以减少、消除或绕过转化过程中的瓶颈。NCATS的愿景是更快地为所有人提供更多的治疗。
NCATS的工作人员是与转化研究和科学政策相关的许多不同领域的专家，从小分子到人类受试者保护。 NCATS提供一系列资助计划和实物支持服务，还为临床前和临床研究人员提供各种工具和其他资源，旨在帮助研究人员将基本的科学知识转化为改善人类健康的干预措施。
NCATS分为若干个部门和办公室，由不同的工作人员指导中心的转化研究活动。
它们分别是：司长办公室，临床创新科，校外活动司，临床前创新事业部，罕见病研究创新科，行政管理办公室，药物开发伙伴关系方案办公室，政策、传播和教育办公室，特别倡议办公室，战略联盟办公室，转化医学办公室。
The National Center for the Advancement of Translational Science (NCATS), one of NIH's 27 institutes and centers, was established in December 2011. Since its inception, NCTS has managed an extensive funding portfolio, including the NIH's largest single-grant program, the Clinical and Translational Science Awards (CTSA).
The staff at NCCATS work hard to meet the enormous challenges of rare disease research so that new treatments can reach people faster. They focus on common situations in the disease and develop solutions to reduce, eliminate, or bypass bottlenecks in the transformation process. NCATS' vision is to deliver more treatment to all, faster.
NCATS staff are experts in many different areas related to translational research and science policy, from small molecules to human subject conservation. NCATS offers a range of grant programs and in-kind support services, as well as tools and other resources for preclinical and clinical researchers designed to help researchers translate basic scientific knowledge into interventions to improve human health.
NCTS is divided into departments and offices, with different staff guiding the Centre's translational research activities.
They are: Office of the Director, Clinical Innovation Division, Division of Extramural Activities, Preclinical Innovation Division, Rare Disease Research and Innovation Division, Office of Administration and Management, Office of Drug Development Partnership Program, Office of Policy, Communication and Education, Office of Special Initiatives, Office of Strategic Alliances, Office of Translational Medicine.